Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT00098839 · COMPLETED

Trial details

NCT number: NCT00098839
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Childhood Acute Lymphoblastic Leukemia

Start date: 2005-02-01
Primary completion: 2011-04-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.